dlt446 dlt446

dlt446 dlt446

Clinical Professor

Member of:

  • Neurology


Publication year:
All
1 - 10 out of 48Page size: 10
Sort by: Title
  1. Published

    A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention

    dlt446, dlt446, Doležil, D., Bonner, J. H., Zhou, L., Klatt, J., Picard, H. & Mikol, D. D., 2021, In: Cephalalgia. 41, 1, p. 33-44 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Amylin analog pramlintide induces migraine-like attacks in patients

    Ghanizada, H., Al-Karagholi, M. A., Walker, C. S., Arngrim, N., Rees, T., Petersen, J., Siow, A., Mørch-Rasmussen, M., Tan, S., O'Carroll, S. J., Harris, P., Skovgaard, Lene Theil, Jørgensen, Niklas Rye, Brimble, M., Waite, J. S., Rea, B. J., Sowers, L. P., Russo, A. F., Hay, D. L. & dlt446, dlt446, 2021, In: Annals of Neurology. 89, 6, p. 1157-1171 15 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Board Walk – April 2021

    dlt446, dlt446 & Katsarava, Z., 2021, In: Cephalalgia. 41, 5, p. 634-636 3 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  4. Published

    Board Walk – August 2021

    dlt446, dlt446, 2021, In: Cephalalgia. 41, 9, p. 1033-1034 2 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  5. Published

    Cerebrovascular effects of glibenclamide investigated using high-resolution magnetic resonance imaging in healthy volunteers

    Al-Karagholi, M. A. M., Ghanizada, H., Nielsen, C. A. W., Ansari, A., Gram, C., Younis, S., Vestergaard, M. B., Larsson, Henrik Bo Wiberg, Skovgaard, Lene Theil, Amin, Faisal Mohammad & dlt446, dlt446, 2021, In: Journal of Cerebral Blood Flow and Metabolism. 41, 6, p. 1328-1337 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Diagnosis and management of migraine in ten steps

    Eigenbrodt, A. K., Ashina, H., Khan, S., Diener, H. C., Mitsikostas, D. D., Sinclair, A. J., Pozo-Rosich, P., Martelletti, P., Ducros, A., Lantéri-Minet, M., Braschinsky, M., del Rio, M. S., Daniel, O., Özge, A., Mammadbayli, A., Arons, M., Skorobogatykh, K., Romanenko, V., Terwindt, G. M., Paemeleire, K. & 7 others, Sacco, S., Reuter, U., Lampl, C., Schytz, Henrik Winther, Katsarava, Z., Steiner, T. J. & dlt446, dlt446, Aug 2021, In: Nature Reviews Neurology. 17, 8, p. 501-514 14 p.

    Research output: Contribution to journal › Review › Research › peer-review

  7. Published

    Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trial

    Wienholtz, N. K. F., Christensen, C. E., Zhang, D. G., Coskun, H., Ghanizada, H., Al-Karagholi, M. A. M., Hannibal, Jens, Egeberg, A., Thyssen, Jacob Pontoppidan & dlt446, dlt446, 2021, In: Cephalalgia. 41, 6, p. 731-748 18 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Effect of Adrenomedullin on Migraine-Like Attacks in Patients With Migraine: A Randomized Crossover Study

    Ghanizada, H., Al-Karagholi, M. A. M., Arngrim, N., Mørch-Rasmussen, M., Walker, C. S., Hay, D. L. & dlt446, dlt446, 18 May 2021, In: Neurology. 96, 20, p. e2488-e2499 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial

    Pellesi, L., Al-Karagholi, M. A. M., De Icco, R., Coskun, H., Elbahi, F. A., Lopez-Lopez, C., Snellman, J., Hannibal, Jens, Amin, F. M. & dlt446, dlt446, 4 Aug 2021, In: JAMA network open. 4, 8, 13 p., e2118543.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study

    dlt446, dlt446, Cohen, J. M., Galic, M., Campos, V. R., Barash, S., Ning, X., Kessler, Y., Janka, L. & Diener, H. C., 2021, In: Journal of Headache and Pain. 22, 68.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 Next

ID: 920785